ProCell Surgical Sponge-Blood Recovery Unit

FDA 510(k) K193361 · Procell Surgical, Inc.

Substantially Equivalent

510(k) numberK193361

Submission

Device name
ProCell Surgical Sponge-Blood Recovery Unit
Applicant
Procell Surgical, Inc.
Toronto, CA
Received
December 4, 2019
Decision date
June 1, 2020
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
CAC – Apparatus, Autotransfusion
Device class
Class II (moderate risk)
Regulation
21 CFR 868.5830
Specialty
Anesthesiology
Life-sustaining
Yes

Other 510(k)s with product code CAC

510(k)DeviceApplicantDecision
K241236XTRA Collection sets; XTRA Sequestration set XCAC · Special Sorin Group Italia S.R.L.08/16/2024SE
K240426Aventus Clot Management SystemCAC · Traditional Inquis Medical05/14/2024SE
K240584XTRA Autotransfusion System (with XTRA Bowl sets)CAC · Special Sorin Group Italia S.R.L.04/29/2024SE
K231782FlowSaver Blood Return System (80-101)CAC · Special Inari Medical, Inc.07/14/2023SE
K221483FlowSaver Blood Return SystemCAC · Traditional Inari Medical, Inc.02/17/2023SE
K221722Haemonetics Cell Saver Elite/Elite+ Autotransfusion System (CSE-E-US/CSE-EW-US)CAC · Traditional Haemonetics Corporation11/15/2022SE
K201305Auto transfusion (ATS) Chest Drains: Ocean Water Seal Chest Drain, Oasis Dry Suction…CAC · Traditional Atrium Medical Corporation09/03/2021SE
K210862Hemafuse SystemCAC · Traditional Sisu Global Health07/29/2021SE
K210176FlowSaver Blood FilterCAC · Traditional Inari Medical07/22/2021SE
K210089CATSmart, Automated Blood Processing Autotransfusion SystemCAC · Special Fresenius Kabi AG02/11/2021SE

Questions and answers

When was ProCell Surgical Sponge-Blood Recovery Unit cleared by the FDA?

ProCell Surgical Sponge-Blood Recovery Unit (K193361) received a 510(k) decision of Substantially Equivalent on June 1, 2020, 180 days after the submission was received.

What is the product code of K193361?

The FDA product code is CAC – Apparatus, Autotransfusion, a Class II (moderate risk) device regulated under 21 CFR 868.5830.